Search Results

0 results for 'Valeant Pharmaceuticals International Inc'

You can use to get even better search results
August 04, 2017 | Corporate Counsel

Proposal for New Rx Pricing Sheriff Greeted With Skepticism

A proposal by the Democratic Party to create a new "price gouging enforcer" in the federal government to stop big price spikes in prescription medications—like the EpiPen—is being greeted by skepticism with health care law experts.
4 minute read
March 30, 2017 |

Growth Surge Ends at Debevoise, But Ex-Partners Return

Debevoise & Plimpton saw its gross revenue, profits per partner and revenue per lawyer and head count drop in 2016. The firm started off 2017 by bringing back former partner and litigation leader Mary Jo White as senior chair.
17 minute read
February 08, 2017 |

BioTime Appoints Industry Vet as First-Ever GC

Industry veteran Stephana Patton will fill the newly created general counsel position at BioTime Inc.
3 minute read
January 24, 2017 |

Ceresney, Back at Debevoise, Predicts Strong SEC Under Trump

As he returns to his old firm, Andrew Ceresney says the U.S. Securities and Exchange Commission won't lose momentum under Donald Trump's administration.
12 minute read
January 24, 2017 |

Ceresney, Back at Debevoise, Predicts Strong SEC Under Trump

As he returns to his old firm, Andrew Ceresney says the U.S. Securities and Exchange Commission won't lose momentum under Donald Trump's administration.
12 minute read
January 19, 2017 | Insurance Coverage Law Center

Senators Release Committee Report of Bipartisan Drug Pricing Investigation

U.S. Senators Susan Collins (R-Maine) and Claire McCaskill (D-Missouri), the chair and the ranking member of the Senate Aging Committee, have released…
3 minute read
January 16, 2017 |

Deal Watch: White & Case Leads on Transactional Tables

White & Case ranked No. 1 for M&A globally in league table rankings for legal advisers in 2016, according to data analyzed by Bloomberg and Mergermarket. The latter listed the Am Law 100 firm as working on 319 announced deals last year valued in excess of $665 billion.
93 minute read
December 01, 2016 |

Trump's Choice of Bharara Sends Message: We'll Bust Corporate Criminals

The decision by President-elect Donald Trump to ask Preet Bharara to stay on as U.S. attorney in Manhattan sends a strong message that the Trump administration is going to be aggressive in prosecuting white-collar crime and corporate misconduct, according to former U.S. Attorney John Wood.
6 minute read
November 17, 2016 |

Clawbacks in the Era of Trump

In his Corporate Securities column, John C. Coffee Jr. of Columbia University Law School examines executive compensation and clawback provisions, writing: The case for broad clawbacks comes into clearer focus when one looks closely at a series of recent corporate scandals, which each raise the same jaw-dropping question: What were those guys thinking?
24 minute read
November 15, 2016 |

How to Help a Whistleblower

This GC-turned-CEO might have been his own worst enemy on the stand.
21 minute read

Resources